ClosedPublished 7 Jul 2022

RetinalGenix Technologies Inc. /
DNA/GPS Inc.

RetinalGenix adds pharmacogenetics company DNA/GPS

Terms
Not stated
Stage
Closed
Buy side: RetinalGenix Technologies Inc.
Buy sideRetinalGenix Technologies Inc.
Source · 7 Jul 2022
Buy side: RetinalGenix Technologies Inc.
Buy sideRetinalGenix Technologies Inc.
01 / BuyerRetinalGenix Technologies Inc.
02 / TargetDNA/GPS Inc.
01

What happened

RetinalGenix Technologies Inc. acquired all outstanding shares of DNA/GPS Inc., a pharmacogenetics company based in Tampa, Florida.

The exchange consideration was 2,000,000 shares of RetinalGenix Technologies Inc.’s common stock.

02

The source

Everything on this page comes from the source below.

01
Source · Source

RetinalGenix adds pharmacogenetics company DNA/GPS

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.